Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: A placebo-controlled study with nebivolol and lisinopril

Journal of Clinical Hypertension

Volumn 14, Issue 9, 2012, Pages 588-592

  Weber, Michael A ^a   Basile, Jan ^b   Stapff, Manfred ^c   Khan, Barbara ^c   Zhou, Dongli ^c  

^a SUNY Downstate Medical Center   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c FOREST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LISINOPRIL; NEBIVOLOL; PLACEBO;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG FATALITY; DRUG SAFETY; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NECK PAIN; NOSE CONGESTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SINUS CONGESTION; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENZOPYRANS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; HUMANS; HYPERTENSION; LISINOPRIL; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84865792645     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2012.00666.x     Document Type: Article

References (19)

1. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC7 report. JAMA. 2003;289:2560-2572.
2. Bakris GL. An approach to achieving recommended blood pressure goals in diabetic patients. Arch Intern Med. 2001;161:2661-2667.
3. Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benzazepril HCl versus comparable component-based therapy. Chem Herit. 2003;9:324-332.
4. Jamerson K, Weber MA, Bakris GL, et al.; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417-2428.
5. Weinberger MH. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. J Cardiovasc Pharmacol. 1985;7(Suppl 1):S22-S55.
6. Cappuccio FP, Markandu ND, Tucker FA, et al. Does a diuretic cause a further fall in blood pressure in hypertensive patients already on nifedipine? J Clin Hypertens. 1986;4:346-353.
7. Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Am Soc Hypertension. 2010;4(2):90-98.
8. Huttunen M, Lampainen E, Lilja M, et al. Which antihypertensive to add to a beta-blocker: ACE inhibitor or diuretic? J Hum Hypertens. 1992;6:121-125.
9. Bursztyn M, Gavras I, Gourley L, et al. Effect of combination therapy with atenolol and the angiotensin-converting enzyme inhibitor benazepril. Clin Ther. 1994;16:429-436.
10. Wing LM, Chalmers JP, West MJ, et al. Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions. J Hypertens. 1987;5:S603-S606.
11. Drayer JLM, Weber MA, Lipson JL, et al. Differential effects of diuresis and betaadrenoreceptor blockade during angiotensin converting enzyme inhibition in patients with severe hypertension. J Clin Pharmacol. 1982;22:179-186.
12. Staessen J, Fagard R, Lijnen P, et al. Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients. Am Heart J. 1983;106:321-328.
13. Ruddy MC, Bialy GB, Kostis JB. Intrinsic sympathomimetic activity counteracts beta-blocker inhibition of renin activation. Angiology. 1989;40:45-50.
14. Wright JT Jr., Bakris GL, Bell DS, et al. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial. J Clin Hypertens. 2007;9:842-849.
15. Bakris GL, Iyengar M, Lukas MA, et al. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study. J Clin Hypertens. 2010;12:678-686.
16. Weiss R. Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilation. Vasc Health Risk Manag. 2006;2:303-308.
17. Neutel JM, Smith DHG, Gradman AH. Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage 1-2 hypertension. J Hum Hypertens. 2010;24:64-73.
18. Kong L, Koch G, Liu T, et al. Performance of some multiple testing procedures to compare three doses of a test drug and placebo. Pharmaceut Statist. 2005;4:25-35.
19. Forest laboratories, Inc. Bystolic: Full Prescribing Information. St Louis, MO: Forest laboratories, Inc; 2011.